Although 3 original studies of HER2 in ESCC indicated that patients without HER2 protein expression exhibited a higher survival rate than those with HER2 expression [33–35], no evidence suggests that HER2 expression may be an independent prognostic predictor in patients with ESCC. This evidence concerns the gene ERBB2 and esophageal squamous cell carcinoma.